The Australian market has shown resilience with the ASX200 closing up 0.51% at 8,416 points, buoyed by a positive response to China’s measured reaction to tariffs and strong performances in sectors like Materials and IT. In this environment of fluctuating global trade dynamics, identifying undervalued stocks becomes crucial for investors seeking opportunities; these are stocks that may be trading below their intrinsic value despite broader market trends. Top 10 Undervalued Stocks Based On Cash Flows In Australia Name Current Price Fair Value (Est) Discount (Est) SKS Technologies Group (ASX:SKS) A$2.10 A$3.83 45.2% Pureprofile (ASX:PPL) A$0.048 A$0.092 47.7% Mader Group (ASX:MAD) A$6.23 A$11.90 47.6% Atlas Arteria (ASX:ALX) A$5.01 A$9.59 47.8% Symal Group (ASX:SYL) A$1.91 A$3.79 49.6% MLG Oz (ASX:MLG) A$0.605 A$1.16 47.9% ReadyTech Holdings (ASX:RDY) A$3.16 A$6.10 48.2% Charter Hall Group (ASX:CHC) A$15.58 A$28.74 45.8% SciDev (ASX:SDV) A$0.48 A$0.87 45% South32 (ASX:S32) A$3.45 A$6.63 47.9% Click here to see the full list of 47 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Nanosonics Overview: Nanosonics Limited is an infection prevention company operating globally, with a market cap of A$1.02 billion. Operations: The company's revenue is primarily derived from its Healthcare Equipment segment, amounting to A$170.01 million. Estimated Discount To Fair Value: 36% Nanosonics is currently trading at A$3.35, significantly below its estimated fair value of A$5.23, suggesting it is undervalued based on discounted cash flow analysis. With forecasted earnings growth of 24.3% annually and revenue growth above the market average, the company shows promising financial prospects despite a recent decline in profit margins from 12% to 7.6%. The appointment of Gerard Dalbosco as an Independent Non-Executive Director could strengthen governance and strategic oversight moving forward. The growth report we've compiled suggests that Nanosonics' future prospects could be on the up. Get an in-depth perspective on Nanosonics' balance sheet by reading our health report here.ASX:NAN Discounted Cash Flow as at Feb 2025 South32 Overview: South32 Limited is a diversified metals and mining company with a market capitalization of approximately A$15.22 billion. Operations: The company's revenue is derived from various segments including Cannington ($631 million), Cerro Matoso ($556 million), Sierra Gorda ($647 million), Brazil Alumina ($484 million), Mozal Aluminium ($812 million), Worsley Alumina ($1.36 billion), Hillside Aluminium ($1.72 billion), Australia Manganese ($436 million), Brazil Aluminium (BA) ($242 million), and South Africa Manganese ($343 million). Story Continues Estimated Discount To Fair Value: 47.9% South32 is trading at A$3.45, well below its estimated fair value of A$6.63, indicating it is undervalued based on discounted cash flow analysis. The company forecasts earnings growth of 51.98% annually and revenue growth of 9.1%, outpacing the Australian market average. Recent production guidance and regulatory approvals for the Worsley Mine Development Project support its operational stability, while new board appointments may enhance strategic direction and governance effectiveness moving forward. Our growth report here indicates South32 may be poised for an improving outlook. Click here and access our complete balance sheet health report to understand the dynamics of South32.ASX:S32 Discounted Cash Flow as at Feb 2025 Symal Group Overview: Symal Group Limited operates in the civil construction industry in Australia, offering services such as construction contracting, equipment hires, material sales, recycling, and remediation, with a market cap of A$455.79 million. Operations: The company generates revenue through its Asset Management (A$88.32 million), Major Infrastructure (A$485.98 million), Construction Services (A$171.86 million), and Plant, People and Logistics (A$21.95 million) segments in the civil construction industry in Australia. Estimated Discount To Fair Value: 49.6% Symal Group, trading at A$1.91, is significantly undervalued with an estimated fair value of A$3.79 based on discounted cash flow analysis. Its earnings are expected to grow annually by 16.8%, surpassing the Australian market's average growth rate of 12.4%. Despite slower revenue growth at 8.9% per year, it remains above market expectations. The recent IPO raised A$136 million, and new board appointments could strengthen governance and strategic oversight. In light of our recent growth report, it seems possible that Symal Group's financial performance will exceed current levels. Click here to discover the nuances of Symal Group with our detailed financial health report.ASX:SYL Discounted Cash Flow as at Feb 2025 Seize The Opportunity Navigate through the entire inventory of 47 Undervalued ASX Stocks Based On Cash Flows here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Contemplating Other Strategies? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:NAN ASX:S32 and ASX:SYL. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 ASX Stocks Estimated Up To 49.6% Below Intrinsic Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...